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Abstract 
Objective. In general the previous epidemiological studies evaluated cases with congenital 
heart defects (CHDs) together. However, different CHD-entities have different etiology, but 
in the vast majority of patients the underlying causes are unclear. The concept of our project 
is to evaluate the possible etiological factors in the origin of CHD-entities as homogeneous as 
possible. The aim of this study is to describe the birth outcomes of 4 different types of cases 
with conotruncal defects (CTDs), i.e. common truncus (truncus arteriosus), transposition of 
great vessels, tetralogy of Fallot, and double-outlet right ventricle. 
Methods. Pregnancy/birth outcomes of 597 live-born cases with CTD, of 902 matched 
controls and 38,151 all controls without any defects were evaluated in the population-based 
large dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities 
completed by socio-demographic variables of their mothers.  
Results.  There was a male excess s in cases with CTD with usual gestational age and preterm 
birth rate (except in cases with common truncus), but their mean birth weight was smaller and 
had a high rate of low birthweight. These data indicate intrauterine growth restriction of 
fetuses affected with CTD with some sex-difference and the birth outcomes al so showed 
some difference among the 4 types of CTD cases. 
Conclusions. Fetal CTD had no effect for gestational age at delivery but CTD associated with 
an obvious risk for fetal development inducing intrauterine growth restriction.  
Keywords: congenital heart defects, conotruncal defect, common truncus (truncus arteriosus), 
transposition of great vessels, tetralogy of Fallot, double-outlet right ventricle, male excess, 
intrauterine growth restriction, population-based case-control study 
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Introduction 
Among structural birth defects, i.e. congenital abnormalities (CAs), CAs of heart and great 
vessels, the so-called congenital heart defects (CHDs) represent the most common group. The 
birth prevalence of cases with CHD was between 4 and 50 per 1000 live-births in different 
studies because their occurrence depends on the age at examination, the sensitivity of the 
examination technique, the case definition and the types of CHDs included [1-7]. A 
Hungarian population-based study of 2,259 children based on the pediatric cardiologic 
examination and/or the evaluation of autopsy report of each individual child, birth prevalence 
of CHDs was found as 10.2 per 1000 [8].   
The care of infants/children with CHD has been revolutionized over the last decades, 
but their underlying causes have been obscured [9]. The strategies for prevention of CHDs 
cannot be developed without the knowledge of their risk or protective factors. Recent progress 
in human genetics has resulted in the identification of several genes causing CHDs [10], 
however, the role of possible environmental factors in the origin of CHDs in the vast majority 
of patients is unclear. Thus the aim of our project is to evaluate the possible etiological factors 
in the origin of CHDs in order to achieve the final goal: to prevent these CAs.  
CHDs cannot be regarded as a single homogeneous CA-group because they have 
different manifestations, severity and etiology, in addition teratogenic factors do not 
uniformly increase the rates of all CHDs but rather tends to increase the occurrence of one or 
a limited number of specific CHDs [11]. Thus our study design was to differentiate CHD-
types according to the recently proposed mechanistic classification of CHDs [12-15]. This 
recent classification split subtypes previously clinically same CHD- types such in ventricular 
septal defects [14]. However, the evaluation of embryonic development and maldevelopment 
of heart and great vessels helped to combine some previously clinically different CHD-
entities into one pathogenetic group such as transposition of great arteries, common truncus 
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(truncus arteriosus), tetralogy of Fallot, and double-outlet right ventricle into one pathogenetic 
subgroup with the name of conotruncal defects (CTDs). CTDs represent the major anatomic 
phenotypes of outflow tract abnormalities, i.e. disturbances in the ventriculo-arterial portion 
of the ascending limb of the primitive S-shaped cardiac loop (the so-called conus or bulbus 
cordis) which will become septated by ridges derived from the endocardial cushions and by 
the aortico-pulmonary septum respectively, to form the divided arterial outflow from the right 
and left ventricles and of the pulmonary artery and aorta [12-15]. 
          The main objective of our study is to evaluate the possible risk factors in the origin of 
4 CTD-types in the population-based Hungarian Case-Control Surveillance of Congenital 
Abnormalities (HCCSCA) [16]. However, first here we describe the birth outcomes of cases 
with different CTD-types and the socio-demographic features of their mothers. 
 
         MATERIALS AND METHODS 
 
The HCCSCA is based on the comparison of the exposures in the study pregnancy of mothers 
of cases and controls. 
The Hungarian Case-Control Surveillance System of Congenital Abnormalities 
Cases with CA including CTD in the HCCSCA were selected from the Hungarian Congenital 
Abnormality Registry (HCAR) [17]. The reporting of cases with CA is mandatory for 
physicians to the HCAR, and most are reported by obstetricians (in Hungary practically all 
deliveries occur in inpatient obstetric clinics and birth attendants are obstetricians) and 
pediatricians (who are working in the neonatal units of inpatient obstetric clinics and various 
general and specialized, e.g. cardiologic inpatient and outpatient pediatric clinics). Autopsy 
was mandatory for all infant deaths and common (80%) in stillborn fetuses during the study 
period. Pathologists sent a copy of the autopsy report to the HCAR if defects were identified 
in stillbirths and infant deaths. Since 1984 prenatal diagnostic centers were also asked to 
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report malformed fetuses diagnosed prenatally with or without elective termination of 
pregnancy to the HCAR. The recorded total (birth + fetal) prevalence of cases with CA was 
35 per 1000 informative offspring (live-born infants, stillborn fetuses and electively 
terminated malformed fetuses) between 1980 and 1996 [17] and about 90% of major CAs 
were recorded in the HCAR [18].  
 Cases reported to the HCAR after the first 3 months of births or termination of 
pregnancies (23% of all cases, affected mainly with mild CA) and cases with CA-syndromes 
caused by gene mutations or chromosomal aberrations with preconception origin were 
excluded from the HCCSCA.  
The so-called controls were defined as newborn infants without CA. The source of 
these controls was the National Birth Registry of the Central Statistical Office for the 
HCCSCA. In general two controls were matched to every case according to sex, birth week in 
the year when the case was born and district of parents’ residence. If controls were twin, only 
one of these twin-pairs was selected randomly for the HCCSCA.  
A structured questionnaire with an explanatory letter and printed informed consent 
was mailed continuously to the address of mothers immediately after the selection of cases 
and controls for the HCCSCA. Mothers were also requested to send us the prenatal maternity 
logbook, discharge summary of their deliveries and every medical record of their child’s CA. 
The questionnaire requested information on maternal characteristics (demographic data, 
history of previous pregnancies, etc.) and pregnancy complications.  
The mean ± S.D. time elapsed between the end of pregnancy and return of the 
“information package” (including logbook, discharge summary, questionnaire and signed 
informed consent) in our prepaid envelope was 3.5 + 2.1 and 5.2 ± 2.9 months in cases and 
controls, respectively. 
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In addition regional district nurses were asked to visit all non-respondent case mothers 
and to help them to fill-in the same questionnaire used in the HCCSCA and to evaluate the 
available medical documents. Unfortunately district nurses could visit only 200 non-
respondent and 600 respondent control mothers in two validation studies [19, 20] because the 
ethics committee considered this follow-up to be disturbing for the parents of all healthy 
children. Another validation study showed the low reliability of retrospective maternal self-
reported information regarding smoking and alcohol drinking during the study pregnancy 
[21]. The number of smokers and alcohol drinkers during the study pregnancy therefore were 
evaluated only in those mothers, who were visited and questioned at home, but these data 
were completed on the basis of cross interview of family members living together, and finally 
the so-called family consensus was recorded. The smoking habit was evaluated on the number 
of cigarettes per day while three groups of drinking habit were differentiated: abstinent or 
occasional drinkers (less than one drink per week), regular drinkers (from one drink per week 
to daily one drink), and hard drinkers (more than one drink per day). 
The necessary information was available for 96.3% of cases (84.4% from replies and 
11.9% from visits) and 83.0% of controls (81.3% from replies and 1.7% from visits). The 
signed informed consent was sent back by 98% of mothers, the name and address were 
deleted in 2% of subjects without signed informed consent. The flow of cases and controls in 
the HCCSCA was reported previously [22]. 
The data of birth outcomes were based on the Notification Form of Cases with CA in 
the HCAR confirmed by the discharge summary of delivery and maternal information in the 
questionnaire. The birth outcomes of controls were evaluated by the help of the latter two data 
sources. The gestational age was calculated from the first day of the last menstrual period. 
The rate of low birthweight (less than 2500 gram) and large birth weight (4500 or more g) 
newborns, in addition the rate of preterm births (less than 37 completed gestation weeks or 
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less than 259 days) and postterm birth (42 or more weeks) were estimated on the basis of 
gestational age at delivery and birth weight on the basis of discharge summaries of deliveries 
in pregnant women. Measurements of birthweight as the indicators of fetal growth are 
expressed in relation to specified gestation weeks.  
Among maternal characteristics, age and birth order (parity) were recorded in the 
HCAR but these variables were checked in the HCCSCA completed by pregnancy order, 
marital and employment status based on the prenatal maternity logbook and maternal 
questionnaire. The maternal employment is good indicator of socioeconomic status in 
Hungary [23]. 
The method of data collection was changed in 1997 (since all case and control mothers 
are visited and questioned at home by regional nurses, but these data have not been validated 
at the time of this analysis), and it explains that here only the 17 years’ dataset of the 
HCCSCA, 1980-1996 are evaluated.  
Study design of CTD 
The major problem of cases with CHD was that about 50% of these cases were reported to the 
HCAR as unspecified CHD, because the exact diagnosis of CHD needed further time 
consuming examinations. The collection of medical, personal and exposure data of cases with 
CA in the HCCSCA was 3.5 + 2.1 months later thus we were able to get specified CHD 
diagnoses in further 20% of cases. However, the rest, i.e. nearly 30% of our CHD cases had 
no specified diagnoses in the HCCSCA. We supposed that most cases with CHD were cared 
or had surgical intervention in the pediatric cardiologic institutions in Hungary, therefore one 
of us (M. Cs-Sz.) visited these cardiologic in- and outpatients clinics in 2008. Medical records 
were reviewed and the previous diagnosis of specified CHDs was checked (and corrected it if 
necessary) and the previous unspecified CHDs were modified to specified CHD diagnoses. 
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        At the evaluation of CTDs we had 3 selection steps. 
          I. Cases with syndromic CTD due to major mutant genes such as CA-syndromes (e.g. 
Holt-Oram) or chromosomal aberrations (e.g. Down syndrome) were excluded from the 
HCCSCA. Unidentified multiple CAs including CTD were also excluded in the study. The 
group of CTD belongs to the complex CAs (more than one CA in the same organ, e.g. heart) 
in the group of isolated CAs, these cases were planned to include the study. 
       II. Only cases with well-defined diagnosis of four well-known types of CTDs were 
included to the study:  
 (i) Truncus arteriosus communis (i.e. common arterial trunk) (TAC) is a CHD in 
which truncus arteriosus is not properly differentiated into the two great arteries. One large 
single artery receiving blood from both right and left ventricles, has one semilunar valve and 
distributes blood to both systematic and pulmonary circulations. The pulmonary artery may 
arise either as a single vessel or as two separate vessels from the trunk. A ventricular septal 
defect is present in all cases. Survival is limited because of a large shunt and eventual 
pulmonary hypertension or left ventricular failure. 
 (ii) Transposition of great arteries (with or without ventricular defects and pulmonary 
or tricuspid atresia) (TGA), the aorta arises from the right ventricle in the anterior position 
and the pulmonary artery from the left ventricle in a posterior position. This complete 
transposition creates two parallel circulations, this situation obviously is incompatible with 
life, thus only surgical intervention can protect the life. Complete transposition of great 
vessels may exist with intact ventricular septum, with ventricular septal defect, with double-
outlet right ventricle and with pulmonary/tricuspid atresia. 
  (iii) Tetralogy of Fallot (TOF), classically this CHD comprises of 4 components: 
large ventricular septal defect, an aorta overriding the ventricular septal defect, severe 
infundibular pulmonic stenosis (small pulmonary valve and pulmonary artery) or atresia and 
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right ventricular hypertrophy. Thus TOF is characterized by biventricular origin of the aorta 
above large ventricular septal defect. TOF causes cyanosis and these patients need surgical 
shunts. 
          (iv) Double-outlet right ventricles (DORV). In this rare CHD (about 1 % of cases 
with CHD), more than 50% of the semilunar valve orifices of both great arteries arise form 
the morphologic right ventricle. In most cases, the ventricles display a D loop, and the 
pulmonary arterial origin is normally positioned, arising from a conus above the right 
ventricle. The aorta also arises from the right ventricle above conal tissue. In most cases, the 
aortic origin is to the right (d-malposition) of the pulmonary arterial origin, with the two 
vessels in a side-by-side relationship. Rarely, the aortic origin is distinctly anterior to the 
pulmonary origin or the aorta arises to the left (l-malposition) of the pulmonary artery. Cases 
with DORV were reported only in the 1990s in the HCAR due to the recent recognition of 
this CHD-entity. 
             III. Only cases with confirmed diagnosis based of surgical records or autopsy reports 
were included to the study, e.g. without surgical intervention DORV is lethal CA. Some cases 
with CTD were not found in the records of cardiologic institutions, in these cases we had a 
correspondence with mothers to clarify the status of their children in 2009 and 2010. Thus 
finally only lethal cases with autopsy report of survival cases with surgical correction were 
included to the study. If parents refused the collaboration or the diagnosis was not 
unequivocal, these cases were excluded from the study. Thus the diagnosis of our CTD cases 
had a high validity.  
         Controls were differentiated into two groups: matched controls of cases with different 
CTD-types evaluated in the study and all controls of the HCCSCA.  
   Statistical analysis 
  
1
The software GNU R version 2.14, RStudio version 0.97 was used for the analysis of 
variables. First, frequency tables were made for the main birth outcomes of cases with CTD, 
and controls. Second, at the evaluation of quantitative data of birth outcomes of newborn 
infants and mothers such as age and pregnancy/birth order, Student t test was used while 
categorical variables of mothers regarding as marital and employment status were analyzed by 
chi square test. At the evaluation of categorical birth outcomes odds ratios (OR) with 95% 
confidence intervals (CI) were calculated in multivariable conditional regression model at the 
comparison of cases and their matched controls, and  multivariable unconditional regression 
model at the comparison of cases and all controls.  
 
RESULTS 
 
Our population-based data set included 598 cases with CTD (Table 1), including 44 cases 
with TAC, 307 cases with TGA, 223 cases with TOF and 24 cases with DORV. In addition, 
we evaluated 902 matched controls and 38,151 all controls without CA and 20,896 
malformed controls with non-cardiac isolated CA. Of 598 cases, one with TOF was diagnosed 
in stillborn male fetus. Matched and all controls were live-born babies due to their selection 
criteria, thus only 297 live-born cases were also evaluated in the study.    
 Cases with TAC had a robust (70.5%), while cases with TGA (55.0%) and TOF 
(57.7%) slight male predominance. The sex ratio of cases with DORV (12; 50.0%) did not 
differ from the expected data of the Hungarian newborn population (51.3 % of males).  
At the evaluation of total group of cases with CTD (Table 2), the mean gestational age 
at delivery was similar in cases and in matched and all of controls. However, the mean birth 
weight was smaller with 163 grams and 199 grams compared to matched controls and all 
controls, respectively. These findings were in agreement with the rate of preterm births and 
low birthweight newborns. The rate of preterm births was somewhat but not significantly 
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lower in the group of cases with CTD than in the groups of matched and all controls while the 
rate of low birthweight was significantly: 2.4-fold and 2.6-fold higher in cases than in the 
matched and all controls.  Thus, the major finding of this analysis is an obvious intrauterine 
fetal growth retardation of cases with CTD. There was a somewhat higher rate of postterm 
birth and large birthweight in cases with CTD though the number of these births was limited.  
We attempted to evaluate the birth outcomes of the 4 types of CT-CVA separately as 
well (Table 3). 
The mean gestational age was much shorter and the mean birth weight was 
significantly smaller in cases with TAC than in their controls and these variables associated 
with a high rate of preterm birth and extremely high rate of low birthweight. These data 
indicate beyond shorter gestational age an obvious intrauterine growth restriction. 
The birth outcomes of cases with TGA showed a controversial pattern. The mean 
gestational age was somewhat longer with lower rate of preterm birth, but the mean birth 
weight was smaller and it associated with a higher rate of low birthweight. Thus intrauterine 
growth restriction was also observed in this type of TGA.  
The pattern of birth outcomes in cases with TOF was also different. The mean 
gestational age was somewhat shorter and the rate of preterm birth was lower in these cases 
than in controls but these differences did not reach the level of significance. However, the 
mean birth was 224 and 279 g smaller with the 2.7 and 2.5 fold higher rate of low birthweight 
newborns in cases with TOF than in their matched and all controls. Thus intrauterine growth 
restriction was also obvious. 
The birth outcomes of cases with DORV were similar to cases with TGA though the 
rate of low birthweight was higher. 
In conclusion, birth outcomes of TGA, TOF and DORV showed some similarities with 
the main characteristic of intrauterine growth restriction. However, TAC had a more obvious 
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male predominance with much worse birth outcomes both in the rate of preterm birth and low 
birthweight.  
Table 4 summarized the birth outcomes of cases with CTD according to sex. The 
mean gestational age of cases did not show obvious difference from the figures of different 
controls either in females or males. Thus the significantly lower rate of preterm birth in 
females cases was an expected finding, similar trend was not seen in male cases. The mean 
birth weight was lower in females than in males both in the groups of cases and in their 
controls as in general. However, female cases had smaller birth weight (194 and 224 g) than 
in their matched and all controls compared to the smaller birth weight (142 and 159 g) in male 
cases than in their controls. Thus there was no significant difference in mean gestational age 
of female and male cases than in their controls but the rate of preterm birth was lower in 
female cases and both sexes had a higher rate of low birthweight due to their intrauterine 
growth restriction.  
             Among maternal variables (Table 5), first the total group of cases with CTD is 
analyzed. The mean maternal age was somewhat higher in case mothers than in all controls 
and particularly in matched control mothers.  The mean birth order of case mothers was 
higher due to larger proportion of multiparous women than of matched and all control 
mothers. There was no difference in mean pregnancy order (live- and stillbirths + 
miscarriages) between case and control mothers and this finding is against the higher rate of 
miscarriages in the previous pregnancies of case mothers. 
          The rate of unmarried mothers was similar among the study groups. There was no 
obvious difference in the distribution of maternal employment status among the study groups, 
though the proportion of housewives was higher in the group of case mothers than in control 
mothers. In Hungary most of these women belonged to the lower socioeconomic status. 
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 Table 6 summarizes the maternal variables in cases with different CTD types. Mean 
maternal age was different among different groups of cases with CTD from the lowest (25.1 
yr) in the group of TAV to the highest in the group of DORV (26.6 yr). The mean birth order 
did not follow the mean maternal age, because it was the highest (2.0) both in the mothers of 
cases with TAC (with the youngest mean maternal age) and in the mothers of cases with 
DORV (i.e. with the eldest mean maternal age). The highest mean pregnancy order was also 
observed in the group of cases with TAC indicating a higher rate of miscarriages in the 
previous pregnancies of these mothers. The previously mentioned lower socio-economic 
status (semi- and unskilled workers, housewives) was found in the mothers of cases with 
different CTD, but it was most obvious in the group of TAC (40.9%) compared to TGA 
(33.2%), TOF (33.8%), DORV (32.4%) and particularly in all controls (28.0%) . 
            Only 58 case mothers were visited at home, 12 (20.7%) smoked cigarettes during the 
study pregnancy.  The proportion of smokers was 19.8% in all control mothers. The number 
of regular and hard drinkers was 5 and 2, together was 7 (12.1) during the study pregnancy of 
case mothers. The rate of regular and hard drinkers together was 1.2% in all control mothers. 
This shows a 10.8-fold increased odds for drinkers (with CI: (3.3 ,  32.9)). 
 
             
DISCUSSION 
The major findings of our study indicated male excess and an intrauterine fetal growth 
restriction  in cases with CTD. 
 The cardiac outflow tract, i.e. the group of CTD had tremendous changes in their 
clinical treatment and understanding in their etiopathogenesis. The first patient with tetralogy 
of Fallot was operated in 1945 by Blalock-Taussig shunt (24) and now most infants affected 
with CTD have surgical intervention in the first year of life with a remarkable survival rate of 
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80%. (The highest mortality is among infants with TAC and DORV.) A major breakthrough 
in the understanding of etiopathogenesis of CTD was the discovery that migrating neural crest 
cells form part of the aorticopulmonary septum and the cardiac outflow tract (25-27). Thus 
CTD are the CA of mesenchymal cell migration with an obvious sensitivity of specific 
environmental agents, e.g. retinoid acid exposure (28) due to specific patterns of retinoic acid 
binding proteins which could lead to a rational interpretation of the timing and action of 
specific teratogens.  
The male excess among cases with CTD found in our and other studies (14, 29-32) is 
worth mentioning because it is against the usual X-linked inheritance and support the 
hypothesis of sex-modified threshold level in CTD polygenic system.  
An important finding of the study is that fetal CTD had no effect for gestational age 
and rate of preterm birth. . However, CTD associate with and obvious risk for fetal 
development and it was recognized on the basis of intrauterine growth retardation. Thus 
intrauterine life hemodynamic alterations due to CTD may affect size and growth patterns 
(33). However, our study showed first the sex difference in the birth outcomes of cases with 
different CDT-types. Female cases had a lower rate of preterm birth. In addition our data 
indicated differences in the birth out comes of CTD-types, e.g., cases with TAC had a higher 
rate of both preterm birth and low birthweight, the other 3 type of CTDs associated with a 
somewhat lower rate of preterm birth but higher  of low birthweight newborns. The mothers 
of TAC had a lower maternal socioeconomic status. 
The somewhat elder mothers found in our and other studies (14, 34) are arguments for 
some genetic predisposition of CTDs.  
Previously many studies showed an association between drinking habit of pregnant 
women and characteristic pattern (fetal alcohol syndrome/effect) of CAs including CHD as 
well in their children (35, 36). Tikkanen and Heinonen (32) found a much higher risk of conal 
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malformations in the children of pregnant women with alcohol drinking during the first 
trimester of pregnancy. Our study confirmed it though it was based only a subsample of our 
material, however, these data were collected through a cross interview of mothers and their 
close family members, excluding the very unreliable maternal self-reported information, and 
the association was strong. 
Our study did not find association of smoking during pregnancy with the higher risk of 
CTD as in other studies (32, 14). 
            The strengths of our study are connected with the large population-based data set of 
the HCCSCA including 597 live-born cases with CTD, 902 matched and 38,151 all controls 
without CAs in the ethnically homogeneous Hungarian (Caucasian) population. The 
ascertainment of cases with CTD was high due to nearly complete surgical intervention (with 
precise diagnosis) and/or infant death (due to obligatory autopsy) in this group of CHDs. 
Prenatal diagnosis of severe CHD fetuses was not introduced in Hungary during the study 
period. Cases with CAs were reported by medical doctors and reported diagnoses were 
critically checked in the HCAR (17). In addition the validity of CHD-diagnoses has been 
improved due to the recent medical records in the HCCSCA (16) and due to the follow-up of 
our cases in cardiologic institutions and correspondence with mothers. We did our best to 
work with cases as homogeneous CHD as possible, therefore syndromic/unidentified multiple 
cases including CTD were excluded from the study. Birth outcomes of cases and controls 
were medically recorded.  
However, there were some weaknesses of our study: (i) The rarity of some CTD-types 
creates difficulties in the evaluation of different anatomic subtypes, e.g. we were not able to 
differentiate the two subtypes of transposition of great vessels on the basis of great artery 
relationship such as transpose (parallel) and normal (spiral) (12) (ii) Data regarding lifestyle 
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factors, such smoking habit and alcohol drinking were available in a subsample of mothers 
visited at home. 
             In conclusion, our findings showed male excess and intrauterine growth restriction  
 
of cases with CTD, some difference in the birth outcomes of male and females cases and of 
different types of CTDs and confirmed the role of regular/hard drinking in the origin of CTDs  
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Table 1. Pregnancy outcomes of cases with the different types of CT-CVA 
 
Data set         Total                  Sex ratio  
                                (No. of boys) 
    
   Stillbirth Postnatal death 
(based on 597 
live-born cases) 
 
Types of CTG    .                         No.        %   No.    No.    %   %    No.    %  
  TAC                                44        7.4    31      0   0.0 70.5    18 40.9  
  TGV                         307      51.3  169      0   0.0 55.0    52 16.9  
  TOF                            223      37.3  128      1   0.5 57.7    43 19.4  
  DORV                       24        4.0    12      0   0.0 50.0      8 33.3  
  Total                       598    100.0  340      1   0.2 57.0  121 20.3  
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Table 2. Live-birth outcomes of cases with conotruncal defect (CTD), in addition of matched and all controls 
 
 
Variables        Cases 
   (N=597) 
    Matched controls 
        (N=902) 
         All controls 
         (N=38,151) 
Livebirth outcomes       No.    %    No.      %   OR  95% CI     No.     %  OR  95% CI 
        Quantitative   Mean   S.D.   Mean S.D.       t=      p= Mean S.D.      t=     p= 
   Gestational age (wk)*     39.4   2.0   39.3 2.1       0.93   0.353     39.4 2.1    0.00   1.000 
   Birth weight (g)** 
  3,077  588 3,240 490      5.61  <0.001   3,276 511   8.22 <0.001 
        Categorical    No.    %    No.     %    OR  95% CI     No.  %    OR    95% CI 
   Twins        13   2.2     11  1.2  1.80  0.80-4.05      410  1.1  2.05  1.17-3.58 
   Preterm birth*        49   8.2     84  9.3  0.87  0.60-1.26   3,496  9.2  0.89  0.66-1.19 
   Postterm birth*          6   1.0       4  0.4  2.28  0.64-8.11        151  0.4  2.55  1.13-5.80 
   Low birthweight**        87 14.6     56  6.2  2.58  1.81-3.67   2,167  5.7  2.83  2.25-3.57 
   Large birthweight**          9   1.5       3    0.3  4.59  1.24-17.0      315   0.8  1.84  0.94-3.58 
*Adjusted for sex of cases/controls, in addition to the age, parity (birth order) and employment status of mothers 
** Adjusted for sex of cases/controls, in addition to the age, parity (birth order), employment status of mothers 
 and gestational age of newborns 
Bold numbers show significant associations 
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Table 3. Live-birth outcomes of cases with different types of CTD, in addition of matched and all controls 
 
Study groups/ 
Birth outcomes 
    Cases 
    
    Matched controls 
              
         All controls 
             
TAC (N=44) (N=58) (N=38,151) 
        Quantitative   Mean   
S.D. 
  Mean S.D.       t=      p= Mean S.D.   t=       p= 
   Gestational age (wk) 
    38.6   3.3   39.6 1.6      1.85    0.069     39.4 2.1     1.61   0.115  
   Birth weight (g) 
  2,919  782 3,305 491     2.87    0.005   3,276 511    3.03    0.004 
        Categorical    No.    %    No.   %      OR    95% CI     No.  %     OR  95% CI 
   Preterm birth*          8 18.2        1  1.7     12.7  1.5-105.6      3,496 9.2      2.2   1.0-4.7 
   Low birthweight**        15 34.1        3  5.2       9.5   2.5-35.5      2,167 5.7      8.6   4.6-16.0 
TGA (N=307) (N=489) (N=38,151) 
        Quantitative   Mean  S.D.   Mean S.D.       t=      p= Mean S.D.    t=     p= 
 Gestational age (wk)* 
    39.5   1.9   39.2 2.1      2.08   0.038     39.4 2.1    0.92   0.359 
 Birth weight (g)** 
  3,150  586 3,235 496     2.11   0.035   3,276 511   3.76   0.001 
        Categorical    No.    %    No.   %      OR  95% CI     No.  %     OR  95% CI 
 Preterm birth*        25   8.1     48  9.8      0.8   0.5-1.4      3,496 9.2     0.9  0.6-1.3  
 Low birthweight**        36 11.7     35  7.2      1.7   1.1-2.8       2,167 5.7     2.2  1.6-3.1 
TOF (N=222)              (N=323) (N=38,151) 
        Quantitative   Mean  S.D.   Mean S.D.       t=      p= Mean S.D.   t=      p= 
   Gestational age (wk)     39.3   1.9   39.4 2.1      0.58  0.563     39.4 2.1    0.78   0.434 
   Birth weight (g) 
  2,997  535 3,221 471     5.05  <0.001   3,276 511   7.77    <0.001 
        Categorical    No.    %    No.   %     OR  95% CI     No.  %     OR  95% CI 
  
2
   Preterm birth*        14         6.3       33  10.2   0.6    0.3-1.1      3,496 9.2    0.7   0.4-1.1 
   Low birthweight**        32 14.4       17  5.3    3.0   1.6-5.6      2,167 5.7     2.8  1.9-4.1 
DORV (N=24) (N=32) (N=38,151) 
        Quantitative   Mean  S.D.   Mean S.D.       t=      p= Mean S.D.    t=     p= 
 Gestational age (wk)*     39.4   2.0   39.5 2.1      0.18  0.086     39.4 2.1   0.00    1.000 
 Birth weight (g)** 
  3,171  563 3,382 584     1.37  0.178   3,276 511  0.91    0.370 
        Categorical    No.    %    No.   %      OR  95% CI     No.  %     OR  95% CI 
 Preterm birth*          2   8.3        2  6.3     1.4   0.2-10.4   3,496 9.2     0.9   0.2-3.8 
 Low birthweight**          4 16.7        1  3.1     6.2   0.7-59.6   2,167 5.7     3.3   1.1-9.7 
*Adjusted for the age, parity (birth order) and employment status of mothers 
** Adjusted for the age, parity (birth order), employment status of mothers and gestational age of newborns 
Bold numbers show significant associations 
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Table 4. Live-birth outcomes of cases with CTD, and their matched and all controls according to the sex of newborns 
 
Variables/ Females        Cases 
   (N=258) 
    Matched controls 
        (N=401) 
         All controls 
         (N=13,352) 
        Quantitative   Mean   S.D.   Mean S.D.       t=      p= Mean S.D.      t=     p= 
   Gestational age (wk)*   39.3    2.0   39.2 2.2      0.60   0.547   39.3 2.1     0.00 1.000 
   Birth weight (g)** 2,963   538 3,157 478     4.72  <0.001 3,187 494    6.63  <0.001 
        Categorical    No.    %    No.     %    OR  95% CI     No.  %     OR  95% CI 
   Preterm birth*    17 
  6.6    47 11.7  0.53 0.30-0.95 1,427 10.7  0.59 0.36-0.97 
   Low birthweight**    42 16.3    30   7.5  2.40 1.46-3.96    929 7.0    2.60 1.86-3.64 
Variables/males     (N=    339)     (N= 501)     (N= 24,799) 
        Quantitative   Mean   S.D.   Mean S.D.       t=      p= Mean S.D.      t=     p= 
   Gestational  age (wk)*   39.4   2.1   39.4 2.0      0.00  1.000   39.4 2.0     0.00  1.000 
   Birth weight (g)** 3,164 611 3,306 491     3.57  0.001 3,323 514    4.72  <0.001 
        Categorical    No.    %    No.    %    OR  95% CI     No.  %     OR  95% CI 
   Preterm birth*    32   9.4    37 7.4    1.31 0.80-2.14 2,069 8.3   1.15  0.79-1.65 
   Low birthweight**    45 13.3    26 5.2    2.80 1.69-4.63 1,238 5.0   2.91  2.12-4.01 
Adjusted for the age, parity (birth order), employment status and folic acid use of mothers 
** Adjusted for the age, parity (birth order), employment status, folic acid use of mothers and gestation age of newborns 
Bold numbers show significant associations 
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Table 5. Main variables of mothers of cases with CTD,in addition of their  matched and all controls 
 
Variables     Case mothers 
     (N=597) 
 Matched control mothers 
         (N=902) 
       All control mothers 
            (N=38,151) 
   Quantitative No.   % No.  %   No.   % 
Maternal age               X23        p=              X23        p= 
       -  19     48       8.0    71   7.9       3,277 8.6        
   20 – 29    426 71.4  674 74.4    27,602 72.3       
   30 -    123 20.6  157 17.4   7,272 19.1 
   Mean, S.D.     25.7   5.0    25.2   4.8    t=        p=        25.5   4.9     t=       p= 
Birth order              X22          p=             X22        p= 
       1   261 43.7   443 49.1 18,209 47.7   
       2 or more   336 56.3   459 50.9 19,942 52.3 
   Mean, S.D.       1.9   1.1       1.7   1.0    t=       p          1.7   0.9     t=       p 
Pregnancy order                 X22       p=             X22       p= 
       1  234 39.2    396 43.9 16,320  42.8    
       2 or more  363 60.8    506 56.1 21,831 57.2 
   Mean, S.D.      2.0   1.3       1.9   1.2     t=      p       1.9   1.2     t=       p 
    
 
  
   Categorical   No.   %   No.    %      X21       p= No.  %      X21                p= 
Unmarried   22   3.7      42   4.7     1,472   3.9   
Employment status                 X26        p=             X26          p= 
   Professional   56   9.4      88   9.8   4,423 11.6 
   Managerial 145 24.3    250 27.7 10,265 26.9 
   Skilled worker 174 29.1    280 31.0 11,908 31.2 
   Semiskilled 
        worker 
100 16.7    161 17.8   
   
  6,161 16.1 
   Unskilled worker   41   6.9      46   5.1   2,187   5.7 
   Housewife   62 10.4      58   6.4   2,354   6.2 
   Others   19   3.2      19   2.1      853   2.2 
  
2
 
Table 6. Main variables of mothers of live-born cases with different types of CTD and all controls 
 
Variables     Cases with 
        TAC 
     (N=44) 
 Cases with 
     TGA        
 (N=307) 
   Cases with      
          TOF 
  (N= 222) 
 Cases with 
     DORV 
     (N=24) 
        Cases with                  All controls                                                      
            CTD  
            (N=597)                (N=38,151) 
   Quantitative No.   % No.  %.   % No.  No.  %     No.    %    No.        %  
Maternal age                                   
       -  19       4       9.1      23     7.5          21   9.5        0       0.0          48   8.0    3,277      8.6  
   20 - 29      33 75.0    215   70.0    160 72.1      18    75.0       426 71.4  27,602    72.3  
   30 –        7 15.9      69   22.5        41 18.4        6 25.0    123 20.6    7,272    19.1  
   Mean, S.D.     25.1   4.1  25.9     5.0   25.3   5.3    26.6        4.3          25.7     5.0      25.5      4.9  
Birth order                                 
       1     16 36.4    137   44.6    101 45.5         6 25.0    261 43.7  18,209     47.7  
       2  or more     28 63.6    170   55.4    121 54.5       18    75.0       336 56.3  19,942     52.3  
   Mean, S.D.       2.0   1.2    1.9     1.2     1.8   1.1      2.0    0.8          1.9     1.1        1.7       0.9  
Pregnancy order                                     
       1     14 31.8    123   40.1      91 41.0         6 25.0    234 39.2  16,320     42.8  
       2 or more     30 68.2    184   59.9    131 59.0       18    75.0       336 60.8  21,831     57.2  
   Mean, S.D.      2.3   1.4    2.0     1.2     2.0   1.3       2.2      1.0           2.0     1.3        1.9       1.2  
   Categorical   No.   %   No.   %.   No.    %    No.      %       No.               %     No.          %  
Unmarried       3   6.8       9     2.9      10   4.5        0    0.0       22   3.7    1,472       3.9  
Employment status                               
   Professional       2   4.5      33   10.7      19   8.6        2   8.3      56   9.4    4,423      11.6  
   Managerial       7 15.9      77   25.1      52 23.4        9    37.1       145 24.3  10,265      26.9  
   Skilled worker     15 34.1      87   28.3      68 30.6        4 16.7    174 29.1  11,908      31.2  
   Semiskilled 
      worker 
      7 15.9      51   16.6      38 17.1        4    16.7       100 16.7    6,161      16.1  
   Unskilled worker 
        
      6 13.6      19     6.2      15   6.8        1   4.2      41   6.9    2,187        5.7  
   Housewife       5 11.4      32   10.4      22   9.9        3  12.5      62 10.4    2,354        6.2  
   Others       2   4.5        8     2.6        8   3.6        1    4.2      19   3.2       853        2.2  
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